(Q38449651)

3 September 2017

Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies (English)

1 reference

3 September 2017

1 reference

4

Mary B Daly

1 reference

3 September 2017

Isabelle H Roland

1

1 reference

3 September 2017

Wan-Lin Yang

2

1 reference

3 September 2017

Dong-Hua Yang

3

1 reference

3 September 2017

Robert F Ozols

5

1 reference

3 September 2017

Thomas C Hamilton

6

1 reference

3 September 2017

Henry T Lynch

7

1 reference

3 September 2017

Andrew K Godwin

8

1 reference

3 September 2017

Xiang-Xi Xu

9

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

3 September 2017

1 reference

3 September 2017

98

1 reference

3 September 2017

2607-2623

1 reference

3 September 2017

12

1 reference

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

3 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Two genetic hits (more or less) to cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Cell growth regulation in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

The biology of ovarian cancer development.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Molecular biology of gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Early de novo ovarian carcinoma. A study of fourteen cases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Specific keynote: chemoprevention of ovarian cancer: the journey begins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens fromBRCA1 heterozygotes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Histologic changes in the ovaries of cancer-prone women: an indication of premalignant change?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Precursor lesions of ovarian epithelial malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Mechanism of mammalian ovulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Formation of the rupture site in preovulatory hamster and mouse follicles: loss of the surface epithelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Collagen synthesis inhibition by PGE2 within the human follicular wall--one possible mechanism underlying ovulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Effects of indomethacin on preovulatory follicles in immature, superovulated mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Reproductive consequences of COX-2 inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Disruption of cyclooxygenase genes in mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Tissue architecture: the ultimate regulator of epithelial function?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Normal and abnormal aspects of proteinuria. Part I: Mechanisms, characteristics and analyses of urinary protein. Part II: Clinical considerations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Cancer biology: extracellular proteinases in malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Disabled-2 inactivation is an early step in ovarian tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Molecular aspects of mammalian ovulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

An ultrastructural study of preovulatory apical development in mouse ovarian follicles: effects of indomethacin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Incessant ovulation--a factor in ovarian neoplasia?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11847

7 January 2021

Identifiers

DOI

10.1002/CNCR.11847

1 reference

3 September 2017

1 reference